Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.34B | 2.70B | 1.82B | 1.43B | 1.17B | 959.22M |
Gross Profit | 404.91M | 296.69M | 201.03M | 184.28M | 128.73M | 166.23M |
EBITDA | 1.54M | -77.44M | -105.30M | -113.53M | -161.81M | 9.47M |
Net Income | -50.95M | -128.03M | -148.02M | -149.55M | -195.29M | -22.93M |
Balance Sheet | ||||||
Total Assets | 1.00B | 782.06M | 591.88M | 633.86M | 630.89M | 338.50M |
Cash, Cash Equivalents and Short-Term Investments | 503.78M | 470.65M | 318.82M | 409.55M | 466.60M | 207.31M |
Total Debt | 329.66M | 329.26M | 170.79M | 164.60M | 157.59M | 154.44M |
Total Liabilities | 859.18M | 681.11M | 433.81M | 394.56M | 324.84M | 307.89M |
Stockholders Equity | 140.97M | 99.85M | 156.95M | 238.13M | 306.04M | 30.61M |
Cash Flow | ||||||
Free Cash Flow | 28.41M | -6.65M | -95.18M | -69.20M | -97.14M | -8.15M |
Operating Cash Flow | 63.23M | 34.77M | -59.19M | -45.43M | -78.78M | 7.56M |
Investing Cash Flow | -40.61M | 39.19M | -147.26M | -28.22M | -20.82M | -16.36M |
Financing Cash Flow | 108.67M | 156.03M | 105.00K | 16.59M | 360.13M | 130.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $35.95B | 22.81 | 9.03% | 1.18% | 9.88% | -7.25% | |
70 Outperform | $9.49B | 8.64 | 23.93% | ― | 16.12% | 10.99% | |
68 Neutral | $4.26B | 49.61 | -14.04% | ― | 48.29% | -1436.25% | |
63 Neutral | $14.28B | 7.19 | 7.50% | ― | 12.96% | -23.25% | |
61 Neutral | $3.09B | ― | -38.50% | ― | 49.46% | 66.89% | |
51 Neutral | $7.83B | -0.15 | -40.10% | 2.29% | 21.46% | -2.01% | |
50 Neutral | $1.37B | ― | -12.59% | ― | -4.87% | 66.16% |
At the annual meeting held on June 5, 2025, Alignment Healthcare‘s stockholders voted on several key proposals. Three Class I directors were elected to serve until 2028, Deloitte & Touche LLP’s appointment as the accounting firm for 2025 was ratified, and the executive compensation plan was approved, reflecting confidence in the company’s leadership and strategic direction.